Tobacco components stimulate Akt-dependent proliferation and NFκB-dependent survival in lung cancer cells

Junji Tsurutani, S. Sianna Castillo, John Brognard, Courtney A. Granville, Chunyu Zhang, Joell Gills, Jacqueline Sayyah, Phillip A. Dennis

Research output: Contribution to journalArticle

Abstract

Retrospective studies have shown that patients with tobacco-related cancers who continue to smoke after their diagnoses have lower response rates and shorter median survival compared with patients who stop smoking. To provide insight into the biologic basis for these clinical observations, we tested whether two tobacco components, nicotine or the tobacco-specific carcinogen, 4-(methylnitrosoamino)-1-(3-pyridyl)-1-butanone (NNK), could activate the Akt pathway and increase lung cancer cell proliferation and survival. Nicotine or NNK, rapidly and potently, activated Akt in non-small cell lung cancer (NSCLC) or small cell lung cancer (SCLC) cells. Nicotinic activation of Akt increased phosphorylation of multiple downstream substrates of Akt in a time-dependent manner, including GSK-3, FKHR, tuberin, mTOR and S6K1. Since nicotine or NNK bind to cell surface nicotinic acetylcholine receptors (nAchR), we used RT-PCR to assess expression of nine alpha and three beta nAchR subunits in five NSCLC cell lines and two types of primary lung epithelial cells. NSCLC cells express multiple nAchR subunits in a cell line-specific manner. Agonists of α3/α4 or α7 subunits activated Akt in a time-dependent manner, suggesting that tobacco components utilize these subunits to activate Akt. Cellular outcomes after nicotine or NNK administration were also assessed. Nicotine or NNK increased proliferation of NSCLC cells in an Akt-dependent manner that was closely linked with changes in cyclin D1 expression. Despite similar induction of proliferation, only nicotine decreased apoptosis caused by serum deprivation and/or chemotherapy. Protection conferred by nicotine was NFκB-dependent. Collectively, these results identify tobacco component-induced, Akt-dependent proliferation and NFκB-dependent survival as cellular processes that could underlie the detrimental effects of smoking in cancer patients.

Original languageEnglish (US)
Pages (from-to)1182-1195
Number of pages14
JournalCarcinogenesis
Volume26
Issue number7
DOIs
StatePublished - Jul 2005
Externally publishedYes

Fingerprint

Nicotine
Tobacco
Lung Neoplasms
Survival
Non-Small Cell Lung Carcinoma
Nicotinic Receptors
Smoking
Glycogen Synthase Kinase 3
Cell Line
Cyclin D1
Small Cell Lung Carcinoma
Smoke
Carcinogens
Neoplasms
Cell Survival
Retrospective Studies
Epithelial Cells
Phosphorylation
Cell Proliferation
Apoptosis

ASJC Scopus subject areas

  • Cancer Research

Cite this

Tsurutani, J., Castillo, S. S., Brognard, J., Granville, C. A., Zhang, C., Gills, J., ... Dennis, P. A. (2005). Tobacco components stimulate Akt-dependent proliferation and NFκB-dependent survival in lung cancer cells. Carcinogenesis, 26(7), 1182-1195. https://doi.org/10.1093/carcin/bgi072

Tobacco components stimulate Akt-dependent proliferation and NFκB-dependent survival in lung cancer cells. / Tsurutani, Junji; Castillo, S. Sianna; Brognard, John; Granville, Courtney A.; Zhang, Chunyu; Gills, Joell; Sayyah, Jacqueline; Dennis, Phillip A.

In: Carcinogenesis, Vol. 26, No. 7, 07.2005, p. 1182-1195.

Research output: Contribution to journalArticle

Tsurutani, J, Castillo, SS, Brognard, J, Granville, CA, Zhang, C, Gills, J, Sayyah, J & Dennis, PA 2005, 'Tobacco components stimulate Akt-dependent proliferation and NFκB-dependent survival in lung cancer cells', Carcinogenesis, vol. 26, no. 7, pp. 1182-1195. https://doi.org/10.1093/carcin/bgi072
Tsurutani, Junji ; Castillo, S. Sianna ; Brognard, John ; Granville, Courtney A. ; Zhang, Chunyu ; Gills, Joell ; Sayyah, Jacqueline ; Dennis, Phillip A. / Tobacco components stimulate Akt-dependent proliferation and NFκB-dependent survival in lung cancer cells. In: Carcinogenesis. 2005 ; Vol. 26, No. 7. pp. 1182-1195.
@article{082b4cd267db4290a9b17fb54bb321f4,
title = "Tobacco components stimulate Akt-dependent proliferation and NFκB-dependent survival in lung cancer cells",
abstract = "Retrospective studies have shown that patients with tobacco-related cancers who continue to smoke after their diagnoses have lower response rates and shorter median survival compared with patients who stop smoking. To provide insight into the biologic basis for these clinical observations, we tested whether two tobacco components, nicotine or the tobacco-specific carcinogen, 4-(methylnitrosoamino)-1-(3-pyridyl)-1-butanone (NNK), could activate the Akt pathway and increase lung cancer cell proliferation and survival. Nicotine or NNK, rapidly and potently, activated Akt in non-small cell lung cancer (NSCLC) or small cell lung cancer (SCLC) cells. Nicotinic activation of Akt increased phosphorylation of multiple downstream substrates of Akt in a time-dependent manner, including GSK-3, FKHR, tuberin, mTOR and S6K1. Since nicotine or NNK bind to cell surface nicotinic acetylcholine receptors (nAchR), we used RT-PCR to assess expression of nine alpha and three beta nAchR subunits in five NSCLC cell lines and two types of primary lung epithelial cells. NSCLC cells express multiple nAchR subunits in a cell line-specific manner. Agonists of α3/α4 or α7 subunits activated Akt in a time-dependent manner, suggesting that tobacco components utilize these subunits to activate Akt. Cellular outcomes after nicotine or NNK administration were also assessed. Nicotine or NNK increased proliferation of NSCLC cells in an Akt-dependent manner that was closely linked with changes in cyclin D1 expression. Despite similar induction of proliferation, only nicotine decreased apoptosis caused by serum deprivation and/or chemotherapy. Protection conferred by nicotine was NFκB-dependent. Collectively, these results identify tobacco component-induced, Akt-dependent proliferation and NFκB-dependent survival as cellular processes that could underlie the detrimental effects of smoking in cancer patients.",
author = "Junji Tsurutani and Castillo, {S. Sianna} and John Brognard and Granville, {Courtney A.} and Chunyu Zhang and Joell Gills and Jacqueline Sayyah and Dennis, {Phillip A.}",
year = "2005",
month = "7",
doi = "10.1093/carcin/bgi072",
language = "English (US)",
volume = "26",
pages = "1182--1195",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "7",

}

TY - JOUR

T1 - Tobacco components stimulate Akt-dependent proliferation and NFκB-dependent survival in lung cancer cells

AU - Tsurutani, Junji

AU - Castillo, S. Sianna

AU - Brognard, John

AU - Granville, Courtney A.

AU - Zhang, Chunyu

AU - Gills, Joell

AU - Sayyah, Jacqueline

AU - Dennis, Phillip A.

PY - 2005/7

Y1 - 2005/7

N2 - Retrospective studies have shown that patients with tobacco-related cancers who continue to smoke after their diagnoses have lower response rates and shorter median survival compared with patients who stop smoking. To provide insight into the biologic basis for these clinical observations, we tested whether two tobacco components, nicotine or the tobacco-specific carcinogen, 4-(methylnitrosoamino)-1-(3-pyridyl)-1-butanone (NNK), could activate the Akt pathway and increase lung cancer cell proliferation and survival. Nicotine or NNK, rapidly and potently, activated Akt in non-small cell lung cancer (NSCLC) or small cell lung cancer (SCLC) cells. Nicotinic activation of Akt increased phosphorylation of multiple downstream substrates of Akt in a time-dependent manner, including GSK-3, FKHR, tuberin, mTOR and S6K1. Since nicotine or NNK bind to cell surface nicotinic acetylcholine receptors (nAchR), we used RT-PCR to assess expression of nine alpha and three beta nAchR subunits in five NSCLC cell lines and two types of primary lung epithelial cells. NSCLC cells express multiple nAchR subunits in a cell line-specific manner. Agonists of α3/α4 or α7 subunits activated Akt in a time-dependent manner, suggesting that tobacco components utilize these subunits to activate Akt. Cellular outcomes after nicotine or NNK administration were also assessed. Nicotine or NNK increased proliferation of NSCLC cells in an Akt-dependent manner that was closely linked with changes in cyclin D1 expression. Despite similar induction of proliferation, only nicotine decreased apoptosis caused by serum deprivation and/or chemotherapy. Protection conferred by nicotine was NFκB-dependent. Collectively, these results identify tobacco component-induced, Akt-dependent proliferation and NFκB-dependent survival as cellular processes that could underlie the detrimental effects of smoking in cancer patients.

AB - Retrospective studies have shown that patients with tobacco-related cancers who continue to smoke after their diagnoses have lower response rates and shorter median survival compared with patients who stop smoking. To provide insight into the biologic basis for these clinical observations, we tested whether two tobacco components, nicotine or the tobacco-specific carcinogen, 4-(methylnitrosoamino)-1-(3-pyridyl)-1-butanone (NNK), could activate the Akt pathway and increase lung cancer cell proliferation and survival. Nicotine or NNK, rapidly and potently, activated Akt in non-small cell lung cancer (NSCLC) or small cell lung cancer (SCLC) cells. Nicotinic activation of Akt increased phosphorylation of multiple downstream substrates of Akt in a time-dependent manner, including GSK-3, FKHR, tuberin, mTOR and S6K1. Since nicotine or NNK bind to cell surface nicotinic acetylcholine receptors (nAchR), we used RT-PCR to assess expression of nine alpha and three beta nAchR subunits in five NSCLC cell lines and two types of primary lung epithelial cells. NSCLC cells express multiple nAchR subunits in a cell line-specific manner. Agonists of α3/α4 or α7 subunits activated Akt in a time-dependent manner, suggesting that tobacco components utilize these subunits to activate Akt. Cellular outcomes after nicotine or NNK administration were also assessed. Nicotine or NNK increased proliferation of NSCLC cells in an Akt-dependent manner that was closely linked with changes in cyclin D1 expression. Despite similar induction of proliferation, only nicotine decreased apoptosis caused by serum deprivation and/or chemotherapy. Protection conferred by nicotine was NFκB-dependent. Collectively, these results identify tobacco component-induced, Akt-dependent proliferation and NFκB-dependent survival as cellular processes that could underlie the detrimental effects of smoking in cancer patients.

UR - http://www.scopus.com/inward/record.url?scp=21344464734&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21344464734&partnerID=8YFLogxK

U2 - 10.1093/carcin/bgi072

DO - 10.1093/carcin/bgi072

M3 - Article

VL - 26

SP - 1182

EP - 1195

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 7

ER -